Table of Contents Author Guidelines Submit a Manuscript
BioMed Research International
Volume 2016, Article ID 5438589, 14 pages
http://dx.doi.org/10.1155/2016/5438589
Research Article

Altered Clock and Lipid Metabolism-Related Genes in Atherosclerotic Mice Kept with Abnormal Lighting Condition

1Department of Physiology and Pathophysiology, School of Basic Medical Sciences, Fudan University, Shanghai 200032, China
2Department of Orthopedics, Zhongshan Hospital, Fudan University, Shanghai 200032, China

Received 8 March 2016; Revised 11 May 2016; Accepted 25 July 2016

Academic Editor: Henrik Oster

Copyright © 2016 Zhu Zhu et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. M. R. Ralph, R. G. Foster, F. C. Davis, and M. Menaker, “Transplanted suprachiasmatic nucleus determines circadian period,” Science, vol. 247, no. 4945, pp. 975–978, 1990. View at Publisher · View at Google Scholar · View at Scopus
  2. J. Bass and J. S. Takahashi, “Circadian integration of metabolism and energetics,” Science, vol. 330, no. 6009, pp. 1349–1354, 2010. View at Publisher · View at Google Scholar · View at Scopus
  3. U. Schibler, J. Ripperger, and S. A. Brown, “Peripheral circadian oscillators in mammals: time and food,” Journal of Biological Rhythms, vol. 18, no. 3, pp. 250–260, 2003. View at Publisher · View at Google Scholar · View at Scopus
  4. J. Mendoza, P. Pévet, and E. Challet, “High-fat feeding alters the clock synchronization to light,” Journal of Physiology, vol. 586, no. 24, pp. 5901–5910, 2008. View at Publisher · View at Google Scholar · View at Scopus
  5. K.-F. Storch, O. Lipan, I. Leykin et al., “Extensive and divergent circadian gene expression in liver and heart,” Nature, vol. 417, no. 6884, pp. 78–83, 2002. View at Publisher · View at Google Scholar · View at Scopus
  6. D. M. Flavell, Y. Jamshidi, E. Hawe et al., “Peroxisome proliferator-activated receptor α gene variants influence progression of coronary atherosclerosis and risk of coronary artery disease,” Circulation, vol. 105, no. 12, pp. 1440–1445, 2002. View at Publisher · View at Google Scholar · View at Scopus
  7. O. Froy, “Metabolism and circadian rhythms-implications for obesity,” Endocrine Reviews, vol. 31, no. 1, pp. 1–24, 2010. View at Publisher · View at Google Scholar · View at Scopus
  8. S. Takahashi, I. Inoue, Y. Nakajima et al., “A promoter in the novel exon of hPPARγ directs the circadian expression of PPARγ,” Journal of Atherosclerosis and Thrombosis, vol. 17, no. 1, pp. 73–83, 2010. View at Google Scholar
  9. S. W. Beaven and P. Tontonoz, “Nuclear receptors in lipid metabolism: targeting the heart of dyslipidemia,” Annual Review of Medicine, vol. 57, pp. 313–329, 2006. View at Publisher · View at Google Scholar · View at Scopus
  10. D. Mozaffarian, E. J. Benjamin, A. S. Go et al., “Heart disease and stroke statistics—2015 update: a report from the American Heart Association,” Circulation, vol. 131, no. 4, pp. e29–e322, 2015. View at Publisher · View at Google Scholar
  11. C. M. Shay, H. Ning, S. R. Daniels, C. R. Rooks, S. S. Gidding, and D. M. Lloyd-Jones, “Status of cardiovascular health in US adolescents: prevalence estimates from the National Health and Nutrition Examination Surveys (NHANES) 2005–2010,” Circulation, vol. 127, no. 13, pp. 1369–1376, 2013. View at Publisher · View at Google Scholar · View at Scopus
  12. M. R. F. Linton, P. G. Yancey, S. S. Davies et al., “The role of lipids and lipoproteins in atherosclerosis,” in Endotext, L. J. De Groot, P. Beck-Peccoz, G. Chrousos et al., Eds., MDText.com, South Dartmouth, Mass, USA, 2000. View at Google Scholar
  13. J.-P. Despres, S. Lemieux, B. Lamarche et al., “The insulin resistance dyslipidemic syndrome: contribution of visceral obesity and therapeutic implications,” International Journal of Obesity, vol. 19, supplement 1, pp. S76–S86, 1995. View at Google Scholar · View at Scopus
  14. C. S. Fox, J. M. Massaro, U. Hoffmann et al., “Abdominal visceral and subcutaneous adipose tissue compartments: association with metabolic risk factors in the framingham heart study,” Circulation, vol. 116, no. 1, pp. 39–48, 2007. View at Publisher · View at Google Scholar · View at Scopus
  15. C. B. Anea, M. Zhang, D. W. Stepp et al., “Vascular disease in mice with a dysfunctional circadian clock,” Circulation, vol. 119, no. 11, pp. 1510–1517, 2009. View at Publisher · View at Google Scholar · View at Scopus
  16. M. Ha and J. Park, “Shiftwork and metabolic risk factors of cardiovascular disease,” Journal of Occupational Health, vol. 47, no. 2, pp. 89–95, 2005. View at Publisher · View at Google Scholar · View at Scopus
  17. T. Mohri, N. Emoto, H. Nonaka et al., “Alterations of circadian expressions of clock genes in Dahl salt-sensitive rats fed a high-salt diet,” Hypertension, vol. 42, no. 2, pp. 189–194, 2003. View at Publisher · View at Google Scholar · View at Scopus
  18. J. Xu, W. Yang, Q. Deng, Q. Huang, J. Yang, and F. Huang, “Flaxseed oil and α-lipoic acid combination reduces atherosclerosis risk factors in rats fed a high-fat diet,” Lipids in Health and Disease, vol. 11, article 148, 2012. View at Publisher · View at Google Scholar · View at Scopus
  19. S. Puttonen, M. Kivimäki, M. Elovainio et al., “Shift work in young adults and carotid artery intima-media thickness: the cardiovascular risk in young Finns study,” Atherosclerosis, vol. 205, no. 2, pp. 608–613, 2009. View at Publisher · View at Google Scholar · View at Scopus
  20. S.-I. Imai, C. M. Armstrong, M. Kaeberlein, and L. Guarente, “Transcriptional silencing and longevity protein Sir2 is an NAD-dependent histone deacetylase,” Nature, vol. 403, no. 6771, pp. 795–800, 2000. View at Publisher · View at Google Scholar · View at Scopus
  21. Y. Nakahata, M. Kaluzova, B. Grimaldi et al., “The NAD+-dependent deacetylase SIRT1 modulates clock-mediated chromatin remodeling and circadian control,” Cell, vol. 134, no. 2, pp. 329–340, 2008. View at Publisher · View at Google Scholar · View at Scopus
  22. S. Stein and C. M. Matter, “Protective roles of SIRT1 in atherosclerosis,” Cell Cycle, vol. 10, no. 4, pp. 640–647, 2011. View at Publisher · View at Google Scholar · View at Scopus
  23. J. A. Baur, K. J. Pearson, N. L. Price et al., “Resveratrol improves health and survival of mice on a high-calorie diet,” Nature, vol. 444, no. 7117, pp. 337–342, 2006. View at Publisher · View at Google Scholar · View at Scopus
  24. M. Lagouge, C. Argmann, Z. Gerhart-Hines et al., “Resveratrol improves mitochondrial function and protects against metabolic disease by activating SIRT1 and PGC-1α,” Cell, vol. 127, no. 6, pp. 1109–1122, 2006. View at Publisher · View at Google Scholar · View at Scopus
  25. J. N. Feige, M. Lagouge, C. Canto et al., “Specific SIRT1 activation mimics low energy levels and protects against diet-induced metabolic disorders by enhancing fat oxidation,” Cell Metabolism, vol. 8, no. 5, pp. 347–358, 2008. View at Publisher · View at Google Scholar · View at Scopus
  26. F. Picard, M. Kurtev, N. Chung et al., “Sirt1 promotes fat mobilization in white adipocytes by repressing PPAR-γ,” Nature, vol. 429, no. 6993, pp. 771–776, 2004. View at Publisher · View at Google Scholar · View at Scopus
  27. C. Xu, C. Lu, L. Hua et al., “Rhythm changes of clock genes, apoptosis-related genes and atherosclerosis-related genes in apolipoprotein E knockout mice,” Canadian Journal of Cardiology, vol. 25, no. 8, pp. 473–479, 2009. View at Publisher · View at Google Scholar · View at Scopus
  28. S. H. Zhang, R. L. Reddick, J. A. Piedrahita, and N. Maeda, “Spontaneous hypercholesterolemia and arterial lesions in mice lacking apolipoprotein E,” Science, vol. 258, no. 5081, pp. 468–471, 1992. View at Publisher · View at Google Scholar · View at Scopus
  29. A. S. Plump, J. D. Smith, T. Hayek et al., “Severe hypercholesterolemia and atherosclerosis in apolipoprotein E-deficient mice created by homologous recombination in ES cells,” Cell, vol. 71, no. 2, pp. 343–353, 1992. View at Publisher · View at Google Scholar · View at Scopus
  30. L. Hou, C. Lu, Y. Huang, S. Chen, L. Hua, and R. Qian, “Effect of hyperlipidemia on the expression of circadian genes in apolipoprotein E knock-out atherosclerotic mice,” Lipids in Health and Disease, vol. 8, article no. 60, 2009. View at Publisher · View at Google Scholar · View at Scopus
  31. W. Nelson, Y. L. Tong, J. K. Lee, and F. Halberg, “Methods for cosinor-rhythmometry,” Chronobiologia, vol. 6, no. 4, pp. 305–323, 1979. View at Google Scholar · View at Scopus
  32. H. Esterbauer, G. Wag, and H. Puhl, “Lipid peroxidation and its role in atherosclerosis,” British Medical Bulletin, vol. 49, no. 3, pp. 566–576, 1993. View at Google Scholar · View at Scopus
  33. B. W. McCrindle, E. M. Urbina, B. A. Dennison et al., “Drug therapy of high-risk lipid abnormalities in children and adolescents: a scientific statement from the American Heart Association atherosclerosis, hypertension, and obesity in youth committee, council of cardiovascular disease in the young, with the council on cardiovascular nursing,” Circulation, vol. 115, no. 14, pp. 1948–1967, 2007. View at Publisher · View at Google Scholar · View at Scopus
  34. N. Preitner, F. Damiola, Luis-Lopez-Molina et al., “The orphan nuclear receptor REV-ERBα controls circadian transcription within the positive limb of the mammalian circadian oscillator,” Cell, vol. 110, no. 2, pp. 251–260, 2002. View at Publisher · View at Google Scholar · View at Scopus
  35. I. Lemieux, L. Laperrière, V. Dzavik, G. Tremblay, J. Bourgeois, and J.-P. Després, “A 16-week fenofibrate treatment increases LDL particle size in type IIA dyslipidemic patients,” Atherosclerosis, vol. 162, no. 2, pp. 363–371, 2002. View at Publisher · View at Google Scholar · View at Scopus
  36. W. Verreth, D. De Keyzer, M. Pelat et al., “Weight loss-associated induction of peroxisome proliferator-activated receptor-α and peroxisome proliferator-activated receptor-γ correlate with reduced atherosclerosis and improved cardiovascular function in obese insulin-resistant mice,” Circulation, vol. 110, no. 20, pp. 3259–3269, 2004. View at Publisher · View at Google Scholar · View at Scopus
  37. M. Sasaki, P. Jordan, T. Welbourne et al., “Troglitazone, a PPAR-γ activator prevents endothelial cell adhesion molecule expression and lymphocyte adhesion mediated by TNF-α,” BMC Physiology, vol. 5, no. 1, article 3, 2005. View at Publisher · View at Google Scholar · View at Scopus
  38. K. De Bosscher, W. Vanden Berghe, and G. Haegeman, “Cross-talk between nuclear receptors and nuclear factor κB,” Oncogene, vol. 25, no. 51, pp. 6868–6886, 2006. View at Publisher · View at Google Scholar · View at Scopus
  39. S. Kadiri, C. Monnier, M. Ganbold, T. Ledent, J. Capeau, and B. Antoine, “The nuclear retinoid-related orphan receptor-α regulates adipose tissue glyceroneogenesis in addition to hepatic gluconeogenesis,” American Journal of Physiology—Endocrinology and Metabolism, vol. 309, no. 2, pp. E105–E114, 2015. View at Publisher · View at Google Scholar · View at Scopus
  40. P. Delerive, D. Monté, G. Dubois et al., “The orphan nuclear receptor RORα is a negative regulator of the inflammatory response,” EMBO Reports, vol. 2, no. 1, pp. 42–48, 2001. View at Publisher · View at Google Scholar · View at Scopus
  41. E. Vieira, E. G. Ruano, A. L. C. Figueroa et al., “Altered clock gene expression in obese visceral adipose tissue is associated with metabolic syndrome,” PLoS ONE, vol. 9, no. 11, Article ID e111678, 2014. View at Publisher · View at Google Scholar · View at Scopus
  42. M. Aoki, T. Nata, R. Morishita et al., “Endothelial apoptosis induced by oxidative stress through activation of NF-κB: antiapoptotic effect of antioxidant agents on endothelial cells,” Hypertension, vol. 38, no. 1, pp. 48–55, 2001. View at Publisher · View at Google Scholar · View at Scopus
  43. L. Lin, F. Peng, Y. Liu et al., “Coadministration of VDR and RXR agonists synergistically alleviates atherosclerosis through inhibition of oxidative stress: An In Vivo and In Vitro Study,” Atherosclerosis, vol. 251, pp. 273–281, 2016. View at Publisher · View at Google Scholar
  44. L. K. Fonken, J. L. Workman, J. C. Walton et al., “Light at night increases body mass by shifting the time of food intake,” Proceedings of the National Academy of Sciences of the United States of America, vol. 107, no. 43, pp. 18664–18669, 2010. View at Publisher · View at Google Scholar · View at Scopus
  45. C. Dibner, U. Schibler, and U. Albrecht, “The mammalian circadian timing system: organization and coordination of central and peripheral clocks,” Annual Review of Physiology, vol. 72, pp. 517–549, 2009. View at Publisher · View at Google Scholar · View at Scopus